Helix and QIAGEN Partner to Develop Companion Diagnostics for Hereditary Diseases
Helix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MorePosted by Andy Lundin | Jan 12, 2023 | Company News, Diagnostic Technologies |
Helix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MorePosted by Chris Wolski | Jan 9, 2023 | Molecular Diagnostic Analyzers |
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Chris Wolski | Jan 5, 2023 | Middleware & Software |
These findings give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.
Read MorePosted by Chris Wolski | Jan 5, 2023 | Cervical (HPV) |
The triage approach offers women and labs a more efficient and effective way to diagnose and manage cervical cancer earlier.
Read MorePosted by Andy Lundin | Jan 4, 2023 | Covid 19, Swabs |
Researchers discovered that testing for the presence of a single immune system molecule on nasal swabs can help detect stealthy viruses.
Read More